Yesafili Unione Europea - italiano - EMA (European Medicines Agency)

yesafili

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologici - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Letrozol Viatris Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

letrozol viatris compresse rivestite con film

viatris pharma gmbh - letrozolum - compresse rivestite con film - letrozolum 2.5 mg, lactosum monohydricum 61.5 mg, cellulosum microcristallinum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.14-0.21 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum) pro compresso obducto. - cytostatikum - synthetika

Exemestan Viatris Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

exemestan viatris compresse rivestite con film

viatris pharma gmbh - exemestanum - compresse rivestite con film - exemestanum 25 mg, mannitolum, hypromellosum, crospovidonum, polysorbatum 80, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, silica colloidalis anhydrica, Überzug: carmellosum natricum, maltodextrinum, glucosum monohydricum 0.441 mg, acidum stearicum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.15 - 0.25 mg. - 2nd e 3rd line terapia avanzata di mamma-ca nelle pazienti in postmenopausa - synthetika

Latanoprost Viatris Collirio Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

latanoprost viatris collirio

viatris pharma gmbh - latanoprostum - collirio - latanoprostum 50 µg, natrii chloridum, natrii dihydrogenophosphas monohydricus et dinatrii phosphas corresp. phosphas 6.34 mg, aqua ad iniectabile, benzalkonii chloridum 0.2 mg, ad solutionem pro 1 ml. - il glaucoma - synthetika

Co-Latanoprost Viatris Collirio Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

co-latanoprost viatris collirio

viatris pharma gmbh - latanoprostum, timololum - collirio - latanoprostum 50 µg, timololum 5 mg ut timololi maleas, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 6.33 mg, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad ph, benzalkonii chloridum 0.2 mg, aqua ad iniectabile, ad solutionem pro 1 ml. - stretto, okuläre ipertensione - synthetika

Olmesartan HCT Viatris 20/12.5 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 20/12.5 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 20 mg, hydrochlorothiazidum 12.5 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, pro compresso obducto, natrium 1.4837 mg. - essenziale ipertonia - synthetika

Olmesartan HCT Viatris 20/25 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 20/25 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 20 mg, hydrochlorothiazidum 25 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto, natrium 2.9674 mg. - essenziale ipertonia - synthetika

Olmesartan HCT Viatris 40/12.5 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 40/12.5 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 40 mg, hydrochlorothiazidum 12.5 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto, natrium 2.9674 mg. - essenziale ipertonia - synthetika

Olmesartan HCT Viatris 40/25 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 40/25 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 40 mg, hydrochlorothiazidum 25 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, pro compresso obducto, natrium 2.9674 mg. - essenziale ipertonia - synthetika

Tenofovir Viatris 245 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tenofovir viatris 245 mg compresse rivestite con film

viatris pharma gmbh - tenofovirum disoproxilum - compresse rivestite con film - tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili maleas, cellulosum microcristallinum, lactosum monohydricum 150 mg, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.04 mg, triacetinum, e 171, e 132, pro compresso obducto. - hiv-infektion, epatite b - synthetika